Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin S. Herati, David A. Knorr, Laura A. Vella, et al.
Nature Immunology (2022) Vol. 23, Iss. 8, pp. 1183-1192
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 180
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield, et al.
Nature (2023) Vol. 616, Iss. 7957, pp. 563-573
Open Access | Times Cited: 157
T follicular helper cells in cancer
Nicolás Gutiérrez-Melo, Dirk Baumjohann
Trends in cancer (2023) Vol. 9, Iss. 4, pp. 309-325
Open Access | Times Cited: 105
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 92
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 92
Human circulating and tissue-resident memory CD8+ T cells
Marcus Buggert, David A. Price, Laura K. Mackay, et al.
Nature Immunology (2023) Vol. 24, Iss. 7, pp. 1076-1086
Open Access | Times Cited: 48
Dressing Bacteria With a Hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and Antiviral Immunity
Ying Liu, Mengmeng Zhang, Xinyue Wang, et al.
Advanced Materials (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 57
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
Kensuke Suzuki, Masaki Tajima, Yosuke Tokumaru, et al.
Science Immunology (2023) Vol. 8, Iss. 79
Closed Access | Times Cited: 35
Immunological factors linked to geographical variation in vaccine responses
Marloes M.A.R. van Dorst, Jeremia J Pyuza, Gyaviira Nkurunungi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 250-263
Closed Access | Times Cited: 29
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
Wuji Zhang, Łukasz Kedzierski, Brendon Y. Chua, et al.
Nature Immunology (2023) Vol. 24, Iss. 6, pp. 966-978
Open Access | Times Cited: 24
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
Wolf H. Fridman, Sophie Sibéril, Guilhem Pupier, et al.
Seminars in Immunology (2022) Vol. 65, pp. 101703-101703
Open Access | Times Cited: 37
Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis
Melissa G. Lechner, Zikang Zhou, Aline T. Hoang, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Open Access | Times Cited: 21
Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers
Eve Playoust, Romain Remark, Éric Vivier, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1040-1050
Open Access | Times Cited: 20
Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Mathilde Ruggiu, Marion V. Guérin, Béatrice Corre, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 4
Open Access | Times Cited: 8
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Jie Mei, Xingjian Liu, Huixiang Tian, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 8
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases
Sruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh Bayry
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108399-108399
Open Access | Times Cited: 14
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond
Can Cui, Joseph Craft, Nikhil S. Joshi
Seminars in Immunology (2023) Vol. 69, pp. 101797-101797
Closed Access | Times Cited: 13
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity
W Vos, Adriana Navas, Elise M. G. Meeder, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101215-101215
Open Access | Times Cited: 11
The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer
Lilian Marie Boll, Júlia Perera-Bel, Alejo Rodríguez‐Vida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Potential regulation of artesunate on bone metabolism through suppressing inflammatory infiltration in type 2 diabetes mellitus
Jinghong Luo, Kun Chen, Xiaolin Nong
Immunopharmacology and Immunotoxicology (2025), pp. 1-12
Closed Access
PD-1 suppresses human CD38+circulating Tfr cells and regulates humoral immunity
Heng Zhang, Hui Zheng, Yanchun Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010026-e010026
Open Access
Full-length mRNA sequencing resolves novel variation in 5′ UTR length for genes expressed during human CD4 T-cell activation
Cassandra Woolley, Julia H. Chariker, Eric C. Rouchka, et al.
Immunogenetics (2025) Vol. 77, Iss. 1
Open Access
Multifaceted function of B cells in tumorigenesis
Na Kang, Qinghui Duan, Xin Min, et al.
Frontiers of Medicine (2025)
Closed Access
Page 1 - Next Page

Scroll to top